跳至主要内容
临床试验/NCT02543528
NCT02543528已完成不适用

Echo Ionic Silicone Hydrogel 6-Month Extended Wear Investigation

Johnson & Johnson Vision Care, Inc.2 个研究点 分布在 1 个国家目标入组 171 人开始时间: 2015年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
171
试验地点
2
主要终点
Number of First Occurred Serious and Significant Lens-related Corneal Infiltrative Event (CIE)

研究概览

简要总结

This study is a prospective, randomized, double-masked, bilateral, dispensing, parallel-group clinical trial design. All subjects will participate in a 2-week daily disposable contact lens adaptation period prior to being randomized into one of the four extended wear lenses. The study has a total of 9 scheduled study visits and a total duration of ~197 days. The lenses will be replaced with a fresh pair after 6 nights / 7 days of wear.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 39 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • The subject must read and understand English and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • The subject must be at least 18 and no more than 39 years of age.
  • The subject's spherical equivalent distance refraction must be in the range of -1.00 to -5.50 diopters in each eye.
  • The subject's refractive cylinder must be less than 1.00 diopters in each eye.
  • The subject must have best corrected visual acuity of 20/30 or better in each eye.
  • The subject must be without history of contact lens use in the past 12 months.
  • The subject must have normal eyes (i.e., no ocular medications or infections of any type).

排除标准

  • Any previous experience wearing contact lenses on an overnight or extended wear basis (at least 1 night per month)
  • Currently pregnant or lactating (self reported) (subjects who become pregnant during the study will be discontinued).
  • Currently a regular smoker (1 or more times per month).
  • Current routine swimmer (1 or more times per month).
  • Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
  • Any systemic disease (ex. Sjögren's Syndrome), autoimmune disease (ex. rheumatoid arthritis), or use of medication (ex. chronic steroid use), which may interfere with contact lens wear.
  • Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion by keratometry.
  • Any previous or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser in situ keratomileusis (LASIK), etc.).
  • Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
  • Any ocular infection.
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.
  • History of binocular vision abnormality or strabismus.
  • Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV) by self report).
  • Employee of investigational clinic (e.g., Investigator, Coordinator, Technician).

研究组 & 干预措施

etafilcon A (1-Day) and etafilcon A (Reusable)

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: etafilcon A (Reusable) (Device)

etafilcon A (1-Day) and etafilcon A (Reusable)

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: etafilcon A (1-Day) (Device)

etafilcon A (1-Day) and Investigational Lens 1

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: Investigational Lens 1 (Device)

etafilcon A (1-Day) and Investigational Lens 1

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: etafilcon A (1-Day) (Device)

etafilcon A (1-Day) and Investigational Lens 2

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: Investigational Lens 2 (Device)

etafilcon A (1-Day) and Investigational Lens 2

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: etafilcon A (1-Day) (Device)

etafilcon A (1-Day) and Investigational Lens 3

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: Investigational Lens 3 (Device)

etafilcon A (1-Day) and Investigational Lens 3

Experimental

Prior to randomization, all subjects will participate in a 2-week contact lens adaptation period wearing etafilcon A (1-Day). Subjects will then be randomized to one of four experimental contact lenses to be worn continuously in 6 nights/7 days wear cycles for 6 months of total wear.

干预措施: etafilcon A (1-Day) (Device)

结局指标

主要结局

Number of First Occurred Serious and Significant Lens-related Corneal Infiltrative Event (CIE)

时间窗: Up to 6 months

The number of first serious and significant corneal infiltrative adverse events deemed to be related to contact lens wear (possible, probable or very likely) during a 6-month period (contact lens extended wear period) was assessed via Biomicroscopy. A biomicroscope was used to detect the presence of a corneal infiltrate for each subject eye (Yes: corneal infiltrates detected, No: None present). The number of subjects with corneal infiltrative events was reported for each lens type.

次要结局

  • Overall Comfort Score(Time Frame Up to 6 months)
  • Overall Vision Score(Time Frame Up to 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验